Disclaimer
Copyright Notice
Copyright © 2018 National Comprehensive Cancer Network, Inc., All rights reserved. No portion of this Site or any NCCN Content may be copied, transferred, reproduced, modified, or otherwise used for any purpose without the express written authorization of NCCN. To view the most recent and complete version of the NCCN Guidelines, go online to NCCN.org. The NCCN Guidelines are a work in progress that may be refined as often as new significant data becomes available. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. Please see the terms of the NCCN End-User License Agreement. If you or your organization would like to use, copy, and/or distribute NCCN Content for any purpose, please visit the NCCN Permissions Request Section.
Trademark Notice
NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN®, NCCN GUIDELINES®, NCCN COMPENDIUM®, NCCN BIOMARKERS COMPENDIUM®, NCCN RADIATION THERAPY COMPENDIUM™, NCCN IMAGING AUC™, NCCN TEMPLATES®, NCCN EVIDENCE BLOCKS™, NCCN FRAMEWORK™, NCCN FLASH UPDATES™, NCCN TRENDS™, POWERED BY NCCN™, NCCN ONCOLOGY INSIGHTS REPORTS™, NCCN GUIDELINES FOR PATIENTS® and all other trademarks and service marks associated with NCCN Content (“Marks”) are owned by NCCN. NCCN retains all goodwill and intellectual property rights in such Marks. You shall not use the Marks or any confusingly similar Marks for any commercial purpose, including, without limitation, for purposes of marketing or promoting your services, without the prior written approval of NCCN, which approval may be withheld in NCCN's sole discretion. Each approved use of the Marks shall require the independent written approval of NCCN.
HARBORSIDE PRESS® is a trademark ("HSP Marks") of Harborside Press, LLC. Harborside Press retains all goodwill and intellectual property rights in HSP Marks. Each approved use of the HSP Marks shall require the independent written approval of Harborside Press.
Disclaimer
A) General
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are a statement of consensus of the authors regarding their views of currently accepted approaches to cancer treatment. The NCCN Guidelines for Patients® are derived from the NCCN Guidelines®, which are developed by physicians. The NCCN Imaging AUC are derived from the NCCN Guidelines and define appropriate use criteria for certain imaging services. The recommendations regarding the uses and indications in the NCCN Drugs & Biologics Compendium (NCCN Compendium®) have been derived directly from the NCCN Guidelines. The NCCN Compendium® represents neither an all-inclusive listing of every drug and biologic nor every appropriate use and indication for drugs and biologics. The NCCN Biomarkers Compendium® has been derived directly from the NCCN Guidelines and contains information designed to support decision-making about the use of biomarker testing. The NCCN Biomarkers Compendium® represents neither an all-inclusive listing of every biomarker nor every appropriate use and indication for biomarker testing. The NCCN Radiation Therapy Compendium™ neither represents an all-inclusive listing of radiation therapy recommendations used in cancer treatment nor every oncology-related use and indication for radiation therapy. The NCCN Chemotherapy Order Templates (NCCN Templates®) are peer-reviewed statements of consensus of their authors derived from the NCCN Guidelines for the conditions the NCCN Templates® address. The NCCN Templates are not exhaustive and do not represent the full spectrum of care or treatment options described in the NCCN Guidelines or the NCCN Compendium or include all appropriate approaches or combinations of drugs or biologics for the treatment of cancer. NCCN Templates do not constitute orders. NCCN Evidence Blocks(TM) are derived from the NCCN Guidelines and are intended as a visual representation of five key measures that provide important information about specific recommendations contained within the NCCN Guidelines. NCCN Framework are derived from the NCCN Guidelines and define appropriate treatment pathways at four resource levels—Basic, Core, Enhanced, and NCCN Guidelines.
NCCN Continuing Education programs provide information about NCCN Guidelines and expert approaches to cancer care. Information in the NCCN Continuing Education program does not constitute medical or treatment advice.
The ideas and opinions expressed on JNCCN360.com and in "JNCCN Spotlights" do not necessarily reflect those of NCCN or Harborside Press, LLC. The mention of any product, service, or therapy on this Web site should not be construed as an endorsement of the products mentioned. It is the responsibility of the treating physician or other health-care provider, relying on independent experience and knowledge of the patient, to determine the appropriate treatment for the patient. Readers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each product or therapy to be administered to verify the dosage, method, and duration of administration, or contraindications. Readers are also encouraged to contact the manufacturer with questions about the features or limitations of any products. NCCN and Harborside Press assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.
B) Updates
The NCCN Content is updated at NCCN's discretion to reflect updates and changes by the authors. NCCN will make reasonable efforts to post updated versions of the NCCN Content on the Site provided that NCCN has no obligation to advise any party of updates nor does NCCN have any obligation to update the NCCN Content at any time for any reason.
C) Clinical Trials
NCCN considers clinical trials participation to be appropriate care. Any clinicians seeking to apply or consult the NCCN Content regarding such trials are expected to use independent medical judgment in the context of individual clinical circumstances regarding participation in the trial.
D) No Representations or Warranties
NCCN makes no representations or warranties and explicitly disclaims the appropriateness or applicability of the NCCN Content to any specific patient's care or treatment. Any clinician seeking to treat a patient using the NCCN Content is expected to use independent medical judgment in the context of individual clinical circumstances of a specific patient's care or treatment.
E) WARRANTY DISCLAIMER
NCCN AND HARBORSIDE PRESS MAKE NO WARRANTIES CONCERNING THE NCCN GUIDELINES, THE NCCN COMPENDIUM, THE NCCN TEMPLATES, NCCN GUIDELINES FOR PATIENTS®, OR THE NCCN CONTINUING EDUCATION program, WHICH ARE PROVIDED "AS IS." NCCN AND HARBORSIDE PRESS DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. NCCN AND HARBORSIDE PRESS DO NOT WARRANT THE ACCURACY, CURRENCY APPROPRIATENESS, APPLICABILITY OR COMPLETENESS OF THE NCCN CONTENT, NOR OF ANY PARTICULAR GUIDELINE, TEMPLATE, OR CONTINUING EDUCATION PROGRAM, OR MAKE ANY REPRESENTATION REGARDING THE USE OR THE RESULTS OF THE USE OF THE NCCN CONTENT IN TREATMENT.
F) LIABILITY LIMITATION
IN NO EVENT SHALL NCCN OR ITS MEMBERS OR HARBORSIDE PRESS BE LIABLE FOR ANY DAMAGES OF ANY KIND INCLUDING DIRECT, INCIDENTAL, INDIRECT, SPECIAL, PUNITIVE OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN CONNECTION WITH THE LICENSE GRANTED UNDER THIS AGREEMENT OR USE OF THE NCCN CONTENT INCLUDING, WITHOUT LIMITATION, LOSS OF LIFE, PHYSICAL INJURY, PROPERTY DAMAGE, LOSS OF DATA, LOSS OF INCOME OR PROFIT, OR ANY OTHER DAMAGES, LOSSES OR CLAIMS, EVEN IF NCCN OR HARBORSIDE PRESS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, LOSSES OR CLAIMS.
